Thromboprophylaxis in Critically Ill Patients

NCT00437697 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: dalteparin

Sponsor

Medical University of Vienna